Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Julian and Giuseppe attended the National Ankylosing Spondylitis Society Members Day held in Birmingham on the 8th of June to give an overview of the research work carried in the Knight group, a substantial part being focused on the functional genomics of ankylosing spondylitis.

Julian gave a well-attended presentation highlighting some of the challenges of the work within the group to the audience made up of AS patients and their families, carers and health professionals. The genome-wide association studies (GWAS) results have shown the relevance of regulatory variant and the majority of reported associations have been found to involve non-coding variants. To take forward the results of GWAS and translate them into potential clinical benefits, we carry out research work to define causal regulatory variants, resolve their mode of action and identify the specific modulated genes and pathways which may be therapeutic targets. 


Giuseppe concluded the session presenting two posters showing recent findings using two cutting edge techniques applied to ankylosing spondylitis: Capture-C, which gives a representation of the long range interaction between genes and different parts of the genome, and CRISP-R, a gene editing techniques which allows precise changes at target locations relevant to the disease.